EGF Theramed Health Corp. (CSE:TMED)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
-0.0050 (-7.69%)
At close: Jan 27, 2026
-40.00%
Market Cap 697.00K
Revenue (ttm) n/a
Net Income (ttm) -3.09M
Shares Out 11.62M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 9,220
Open 0.0600
Previous Close 0.0650
Day's Range 0.0600 - 0.0600
52-Week Range 0.0600 - 0.1300
Beta 0.55
RSI 37.08
Earnings Date Feb 26, 2026

About EGF Theramed Health

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada. [Read more]

Sector Healthcare
CEO Connor Yuen
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol TMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.